Department of Medical Physics and Informatics, University of Szeged, Szeged, Hungary.
Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary.
J Cardiothorac Vasc Anesth. 2022 Apr;36(4):1047-1055. doi: 10.1053/j.jvca.2021.07.033. Epub 2021 Jul 24.
To investigate the effects of dopamine on the adverse pulmonary changes after cardiopulmonary bypass.
A prospective, nonrandomized clinical investigation.
A university hospital.
One hundred fifty-seven patients who underwent elective cardiac surgery that required cardiopulmonary bypass.
Fifty-two patients were administered intravenous infusion of dopamine (3 µg/kg/min) for five minutes after weaning from cardiopulmonary bypass; no intervention was applied in the other 105 patients.
Measurements were performed under general anesthesia and mechanical ventilation before cardiopulmonary bypass, after cardiopulmonary bypass, and after the intervention. In each protocol stage, forced oscillatory lung impedance was measured to assess airway and tissue mechanical changes. Mainstream capnography was performed to assess ventilation- and/or perfusion-matching by calculating the normalized phase-3 slopes of the time and volumetric capnograms and the physiologic deadspace. Arterial and central venous blood samples were analyzed to characterize lung oxygenation and intrapulmonary shunt. After cardiopulmonary bypass, dopamineinduced marked improvements in airway resistance and tissue damping, with relatively small decreases in lung tissue elastance. These changes were associated with decreases in the normalized phase-3 slopes of the time and volumetric capnograms. The inotrope had no effect on physiologic deadspace, intrapulmonary shunt, or lung oxygenation.
Dopamine reversed the complex detrimental lung mechanical changes induced by cardiopulmonary bypass and alleviated ventilation heterogeneities without affecting the physiologic deadspace or intrapulmonary shunt. Therefore, dopamine has a potential benefit on the gas exchange abnormalities after weaning from cardiopulmonary bypass.
研究多巴胺对体外循环后肺部不良变化的影响。
前瞻性、非随机临床研究。
一所大学医院。
157 例行体外循环择期心脏手术的患者。
52 例患者在体外循环脱机后 5 分钟内静脉输注多巴胺(3μg/kg/min);另外 105 例患者未给予干预。
在体外循环前、体外循环后和干预后,在全身麻醉和机械通气下进行测量。在每个方案阶段,通过测量强迫振荡肺阻抗来评估气道和组织力学变化。进行主流呼气末二氧化碳监测,通过计算时间和容积呼气末二氧化碳图谱的归一化相位 3 斜率以及生理死腔,评估通气和/或灌注匹配。分析动脉和中心静脉血样以描述肺氧合和肺内分流。体外循环后,多巴胺引起气道阻力和组织阻尼明显改善,肺组织弹性相对较小。这些变化与时间和容积呼气末二氧化碳图谱的归一化相位 3 斜率降低有关。正性肌力药对生理死腔、肺内分流或肺氧合没有影响。
多巴胺逆转了体外循环引起的复杂的肺部力学变化,并减轻了通气不均,而不影响生理死腔或肺内分流。因此,多巴胺对体外循环脱机后气体交换异常有潜在益处。